Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus

Basit Öğe Kaydı
dc.authoridOzdemir, Fatih/0000-0003-0292-3602
dc.authoridince, volkan/0000-0002-0714-490X
dc.authoridKutluturk, Koray/0000-0002-7030-4953
dc.authoridBASKIRAN, ADIL/0000-0002-7536-1631
dc.authoridÖZDEMİR, FATİH/0000-0003-0292-3602
dc.authoridKoc, Cemalettin/0000-0002-5676-6772
dc.authorwosidOzdemir, Fatih/ABH-2875-2020
dc.authorwosidince, volkan/M-7325-2017
dc.authorwosidKutluturk, Koray/S-5493-2019
dc.authorwosidBASKIRAN, ADIL/ABI-2356-2020
dc.authorwosidÖZDEMİR, FATİH/HJI-7585-2023
dc.authorwosidKoc, Cemalettin/B-6430-2018
dc.contributor.authorAdil, B.
dc.contributor.authorFatih, O.
dc.contributor.authorVolkan, I.
dc.contributor.authorBora, B.
dc.contributor.authorVeysel, E.
dc.contributor.authorKoray, K.
dc.contributor.authorCemalettin, K.
dc.date.accessioned2024-08-04T20:42:47Z
dc.date.available2024-08-04T20:42:47Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground. In this study, we retrospectively analyzed the recurrence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infection after liver transplantation for HBV and HBV+HDV co-infection. Methods. Data from patients infected with HBV and HBV+HDV who underwent liver transplantation between March 2003 and June 2013 at the Liver Transplantation Institute of Inonu University were analyzed retrospectively. A total of 255 patients were included in the study. Group 1 (n = 127) comprised patients who underwent liver transplantation because of HBV, and group 2 (n = 128) comprised patients who underwent liver transplantation because of HBV+HDV. A positive HDV antibody serologic test result was taken to indicate liver disease caused by HBV+HDV. Results. Thirteen of 255 were positive for the HBs Ag (5.1%). Nine (7.1%) and 4 (3.1%) patients were positive for the HBs Ag in groups 1 and 2, respectively (7.1%); the difference was not significant (P = .150). No HDV recurrence was detected in either group. The average time to HBs Ag seroconversion in 13 patients was 7.8 months after surgery (6.34 months in group 1 and 11.1 months in group 2). Conclusions. In our study, recurrence rate of HBV after liver transplantation is not statistically different than the recurrence rate of HBV+HDV co-infection. A low recurrence rate was achieved by the prophylaxis protocol in use at our center. There is no standard protocol for prevention of HBV and HDV recurrence; therefore, we need new studies.en_US
dc.identifier.doi10.1016/j.transproceed.2016.02.076
dc.identifier.endpage2123en_US
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue6en_US
dc.identifier.pmid27569956en_US
dc.identifier.scopus2-s2.0-84995965453en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage2119en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2016.02.076
dc.identifier.urihttps://hdl.handle.net/11616/97593
dc.identifier.volume48en_US
dc.identifier.wosWOS:000383528700044en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectImmune Globulinen_US
dc.subjectSurface-Antigenen_US
dc.subjectHbv Dnaen_US
dc.subjectLamivudineen_US
dc.subjectProphylaxisen_US
dc.subjectCombinationen_US
dc.subjectReinfectionen_US
dc.subjectCirrhosisen_US
dc.subjectAntibodyen_US
dc.titleHepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virusen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu